Mobile

A Randomized, Double-blind, Parallel-group, Multicenter Study to Evaluate the Retention Rate, Efficacy, Safety, and Tolerability of Carisbamate, Topiramate and Levetiracetam as Adjunctive Therapy in S...

Mise à jour : Il y a 4 ans
Référence : EUCTR2007-002929-78

A Randomized, Double-blind, Parallel-group, Multicenter Study to Evaluate the Retention Rate, Efficacy, Safety, and Tolerability of Carisbamate, Topiramate and Levetiracetam as Adjunctive Therapy in Subjects with Partial Onset Seizures Estudio aleatorizado, doble ciego, de grupos paralelos, multicéntrico para evaluar el índice de retención, eficacia, seguridad y tolerabilidad de Carisbamato, Topiramato y Levetiracetam como terapia adyuvante en pacientes con crisis epilépticas parciales

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

The primary objective of this study is to demonstrate the long-term retention rate of CRS versus TPM and LEV when given adjunctively to subjects with partial onset seizures over a 6-month period.

Critère d'inclusion

  • Partial onset seizures Crisis Epilépticas Parciales

Liens